Evidence map›Paper›PMID 41941636›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis.

Lucien P Garo, Kevin Brueck, Sarah Walachowski, Archana Jayaraman, Marcel Strueve, Shuang Xu, Hulbert Yang, Matthew Helmkamp, Seung Hoan Choi, Christoph Reinhardt and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Lucien P Garo *Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0000-0001-5369-1958
Kevin Brueck *Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.
Sarah WalachowskiPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0000-0001-5702-3404
Archana JayaramanPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0000-0003-0871-6305
Marcel StrueveCenter for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany.ORCID 0000-0002-0296-4343
Shuang XuPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0009-0004-7731-5585
Hulbert YangPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0009-0007-4371-4790
Matthew HelmkampPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0009-0005-7657-3301
Seung Hoan ChoiDepartment of Biostatistics, Boston University School of Public Health, Boston, MA 02119.
Christoph ReinhardtCenter for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany.ORCID 0000-0002-0696-2636
Markus BosmannPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA 02119.ORCID 0000-0003-2773-1033

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
Interleukin-27 in host response to Legionella infectionR01HL166588 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Markus Bosmann · 2023 to 2026
$2.8M
Role reversal of MAVS in bacterial sepsisR01HL141513 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOSMANN, MARKUS · 2018 to 2022
$2.4M
New genetic models for C5a receptorsR01HL139641 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOSMANN, MARKUS · 2018 to 2022
$2.1M
Full Spectrum Cell Sorter with Imaging Enhancement for Boston University Flow Cytometry Core FacilityS10OD038346 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BELKINA, ANNA · 2025 to 2025
$656k
The Role of Proton-Activated Chloride Channel 1 (PACC1) in Bacterial Pneumonia and SepsisF31HL176388 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lucien Peter Garo · 2024 to 2026
$149k
Deutsche Forschungsgemeinschaft (DFG) BO3482/3-3Deutsche Forschungsgemeinschaft (DFG) BO3482/4-1Federal Ministry of Education and Research 01EO1503HHS | NIH (NIH) 1R01HL139641HHS | NIH (NIH) 1R01HL141513HHS | NIH (NIH) 1R01HL166588HHS | NIH (NIH) 5T32HL007035-50HHS | NIH (NIH) F31HL176388-01A1NHLBI NIH HHS F31 HL176388NHLBI NIH HHS R01 HL139641NHLBI NIH HHS R01 HL141513NHLBI NIH HHS R01 HL166588NHLBI NIH HHS T32 HL007035NIH HHS S10 OD038346
6 · The paper itself

Abstract

Bacterial sepsis remains a devastating clinical problem. Here, we describe a protective role for the recently discovered acid-sensitive, proton-activated chloride channel, PACC1 (PAC/ASOR/TMEM206), during sepsis. Initially, we found PACC1 was enriched in healthy human and mouse mononuclear phagocytes, particularly macrophages, and differentially regulated by inflammatory stimuli, suggesting PACC1 involvement in innate immunity. To further investigate, we generated

Indexed as

Chloride ChannelsEscherichia coli InfectionsImmunity, InnateSepsisAnimalsCytokinesEscherichia coliHumansMacrophagesMiceMice, Inbred C57BLMice, KnockoutPhagocytosisPhagosomesChloride ChannelsCytokinescytokinesimmunologyinfectioninnate immunity

Identifiers

PMID41941636
PMCPMC13079969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.